Ocugen (MEX:OCGN) E10: MXN-595.40 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:OCGN Ocugen Inc MEX:OCGN
35 GF Score
Price MXN20.68
GF Value MXN13.07
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ocugen E10?

Ocugen MEX:OCGN 35 E10 is MXN-595.40 as of Mar. 2026. GuruFocus rates MEX:OCGN with a GF Score™ of 35/100 and a GF Value™ of MXN13.07 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ocugen's adjusted earnings per share data for the three months ended in Mar. 2026 was MXN-1.082. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-595.40 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-02), Ocugen's current stock price is MXN20.68. Ocugen's E10 for the quarter that ended in Mar. 2026 was MXN-595.40. Ocugen's Shiller PE Ratio of today is .


Ocugen  (MEX:OCGN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ocugen E10 Related Terms


Ocugen E10 Historical Data

* Premium members only.

The historical data trend for Ocugen's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocugen E10 Chart

Ocugen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -1,034.61 -1,161.53 -712.28

Ocugen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,065.50 -981.60 -775.35 -712.28 -595.40

MEX:OCGN vs EVMN, PBYI, LRMR: E10 Comparison

For the Biotechnology subindustry, Ocugen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocugen Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocugen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ocugen's Shiller PE Ratio falls into.


MEX:OCGN
35GF Score
Ocugen Inc MEX:OCGN
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ocugen E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ocugen's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-1.082/330.2130*330.2130
=-1.082

Current CPI (Mar. 2026) = 330.2130.

Ocugen Quarterly Data

per share eps CPI Adj_EPS
201606 -676.849 241.018 -927.335
201609 -812.075 241.428 -1,110.715
201612 -779.307 241.432 -1,065.879
201703 -305.024 243.801 -413.136
201706 -271.135 244.955 -365.505
201709 -250.437 246.819 -335.053
201712 -306.370 246.524 -410.375
201803 -566.818 249.554 -750.021
201806 -153.263 251.989 -200.840
201809 -269.347 252.439 -352.330
201812 -169.840 251.233 -223.233
201903 -139.663 254.202 -181.425
201906 -34.575 256.143 -44.573
201909 -70.084 256.759 -90.134
201912 4.437 256.974 5.702
202003 -1.641 258.115 -2.099
202006 -4.386 257.797 -5.618
202009 -1.546 260.280 -1.961
202012 -0.410 260.474 -0.520
202103 -0.818 264.877 -1.020
202106 -2.588 271.696 -3.145
202109 -1.028 274.310 -1.238
202112 -1.436 278.802 -1.701
202203 -1.792 287.504 -2.058
202206 -1.811 296.311 -2.018
202209 -2.011 296.808 -2.237
202212 -1.950 296.797 -2.170
202303 -1.442 301.836 -1.578
202306 -1.714 305.109 -1.855
202309 -0.871 307.789 -0.934
202312 -0.679 306.746 -0.731
202403 -0.830 312.332 -0.878
202406 -1.099 314.175 -1.155
202409 -0.985 315.301 -1.032
202412 -1.043 315.605 -1.091
202503 -1.023 319.799 -1.056
202506 -0.941 322.561 -0.963
202509 -1.284 324.800 -1.305
202512 -1.080 324.054 -1.101
202603 -1.082 330.213 -1.082

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN-595.40 mean?
Ocugen (MEX:OCGN) has a E10 of MXN-595.40 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ocugen and its competitors.
Is Ocugen's E10 too high?
Ocugen's current E10 is MXN-595.40. Overall, Ocugen has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ocugen's E10 compare to EVMN and PBYI?
Ocugen's E10 of MXN-595.40 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ocugen and its competitors. Ocugen's current E10 is MXN-595.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocugen stock overvalued right now?
Based on GuruFocus' analysis, Ocugen (MEX:OCGN) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN13.07, compared to a current price of MXN20.68 — trading 58.2% above its estimated fair value. The current E10 is MXN-595.40. Ocugen's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Ocugen (MEX:OCGN), the current E10 is MXN-595.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ocugen (MEX:OCGN) Overvalued in 2026?

Based on GuruFocus' analysis, Ocugen stock appears to be overvalued. The current stock price of MXN20.68 is trading 58.2% above its estimated GF Value™ of MXN13.07. GuruFocus considers Ocugen to be Significantly Overvalued.

Key valuation signals for MEX:OCGN:

  • E10: MXN-595.40
  • GF Value™: MXN13.07 vs. price of MXN20.68 (58.2% above fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the MEX:OCGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ocugen Business Description

Other Exchanges OCGN:USA2H51:Germany
Address 11 Great Valley Parkway, Malvern, PA, USA, 19355
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
35GF Score

Get the complete analysis for MEX:OCGN

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN20.68
Price
MXN13.07
GF Value